EP Europace · 2021 · 23 citations · 18 references
MedicineCardiologyInterventional CardiologyPatient SafetyPerioperative Quality ImprovementAtrial FibrillationCatheter AblationReadmission AnalysisReadmission Outcomes30-Day ReadmissionCause-specific ReadmissionCohort Study InvestigationHealthcare Cost ConsiderationPrimary Outcome AnalysisPropensity Score AdjustmentReadmission RatesThirty-day Readmission
AIMS: The effectiveness and safety of same-day discharge (SDD) for catheter ablation (CA) for atrial fibrillation (AF) has not been fully elucidated using a large nationwide database. This study aimed to evaluate the all-cause readmission rates within 30-days among patients receiving CA for AF with an SDD protocol compared with a conventional overnight stay (ONS). METHODS AND RESULTS: We performed a retrospective cohort study using the US Nationwide Readmission Database. The primary outcome was all-cause 30-day readmission following discharge in patients receiving CA and a secondary outcome was requiring total healthcare cost. A 1 : 3 propensity score matching was conducted to compare the safety and efficacy within both SDD and ONS group. Among 30 776 patients [mean 67.2 ± 11.4 years, 12 590 female (41.5%)] who received CA from 2016 through 2018, 440 (1.42%) patients were discharged on the same-day following CA (SDD group), and the remaining 30 336 patients stayed at least one night in the hospital (ONS group). A propensity score analysis generated 1751 matched pairs (440 in the SDD group; 1311 in the ONS group). The 30-day readmission following discharge was not significantly higher in the SDD group than the ONS group (SDD vs. ONS: 12.7% vs. 9.7%; hazard ratio: 1.17, 95% confidence interval: 0.76-1.81, P = 0.47). Healthcare cost was significantly higher in the ONS group ($25 237 ± 14 036 vs. $30 749 ± 16 383; P < 0.01). CONCLUSION: In this nationwide database study, there was no significant difference in the all-cause 30-day readmission following SDD for CA compared with ONS.
18
Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation
Jason G. Andrade, George A. Wells, Marc W. Deyell et al. · New England Journal of Medicine · 2020 · 793 citations · Full text